Drug Development Pipeline
| Compound | IND | Ph I | Ph II | Ph III | NDA/MAA | Market |
|---|---|---|---|---|---|---|
| AL3818/Catequentinib Hydrochloride (VEGFr, FGFr) |
|
|||||
| ||||||
| AL8326 (AuroraB, VEGFr, FGFr) |
| |||||
| ||||||
| AL2846 (c-Met) |
| |||||
| AL58805 (mTor/pi3k) |
| |||||
| ||||||
| AL28979 (EGFr/T790M, C797S) |
|
| Compound | IND | Ph I | Ph II | Ph III | NDA/MAA | Market |
|---|---|---|---|---|---|---|
| AL3818/Catequentinib Hydrochloride (VEGFr, FGFr) |
|
|||||
| ||||||
| AL8326 (AuroraB, VEGFr, FGFr) |
| |||||
| ||||||
| AL2846 (c-Met) |
| |||||
| AL58805 (mTor/pi3k) |
| |||||
| ||||||
| AL28979 (EGFr/T790M, C797S) |
|